1. Fernandez O, Alvarez-Cermeno JC, Arroyo-Gonzalez R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, de las Heras V, Garcia-Merino JA, Hernandez-Perez MA, Izquierdo G, Meca-Lallana JE, Munoz-Garcia D, Olascoaga J, Oreja-Guevara C, Prieto JM, Ramio-Torrenta L, Rodriguez-Antiquedad A, Romero-Pinel L, Sanchez F, Tellez N, Tintore M, Montalban X, Post-ECTRIMs group: Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II). Rev Neurol. 2012, 54 (12): 734-749.
2. Krupp LB, Rizvi SA: Symptomatic Therapy for Underrecognized Manifestations of Multiple Sclerosis. Neurology. 2002, 58 (8 Suppl 4): 32-39.
3. Confavreux C, Aimard G, Devic M: Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain. 1980, 103 (2): 281-300. 10.1093/brain/103.2.281.
4. Stern M: Aging with multiple sclerosis. Phys Med Rehabil Clin. 2005, 16 (1): 219-234. 10.1016/j.pmr.2004.06.010.
5. Koch-Henriksen N, Bronnum-Hansen H, Stenager E: Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry. 1998, 65 (1): 56-59. 10.1136/jnnp.65.1.56.